ZNF469 and keratoconus: Recently, two studies identified that missense variants in ZNF469 have been identified in 12.5% and 23.3% of sporadic KC patients in UK/Switzerland and New Zealand, respectively [209, 210], indicating the potential role of ZNF469 in the development of KC.